Evidence map›Paper›PMID 35459889›Full record

ArticleScientific reports2022

Maternal breast milk microbiota and immune markers in relation to subsequent development of celiac disease in offspring.

Jelena Štšepetova, Kärt Simre, Aili Tagoma, Oivi Uibo, Aleksandr Peet, Heli Siljander, Vallo Tillmann, Mikael Knip, Reet Mändar, Raivo Uibo

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Frontiers in gastroenterology (Lausanne, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jelena Štšepetova *Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila Street 19, 50411, Tartu, Estonia. jelena.stsepetova@ut.ee.
Kärt Simre *Department of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 19, 50411, Tartu, Estonia. kart.simre@kliinikum.ee.
Aili TagomaDepartment of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Oivi UiboChildren's Clinic, Tartu University Hospital, Lunini 6, 50406, Tartu, Estonia.
Aleksandr PeetChildren's Clinic, Tartu University Hospital, Lunini 6, 50406, Tartu, Estonia.
Heli SiljanderPediatric Research Center, Children's Hospital, University of Helsinki, Helsinki University Hospital, Stenbäckinkatu 9, PO Box 347, Helsinki, Finland.
Vallo TillmannChildren's Clinic, Tartu University Hospital, Lunini 6, 50406, Tartu, Estonia.
Mikael KnipPediatric Research Center, Children's Hospital, University of Helsinki, Helsinki University Hospital, Stenbäckinkatu 9, PO Box 347, Helsinki, Finland.ORCID 0000-0003-0474-0033
Reet MändarDepartment of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila Street 19, 50411, Tartu, Estonia.
Raivo UiboDepartment of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Tartu University Hospital · EEUniversity of Tartu · EEUniversity of Helsinki · FICompetence Centre on Health Technologies (Estonia) · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential impact of the composition of maternal breast milk is poorly known in children who develop celiac disease (CD). The aim of our study was to compare the microbiota composition and the concentrations of immune markers in breast milk from mothers whose offspring carried the genetic predisposition to CD, and whether they did or did not develop CD during follow-up for the first 3 years of life. Maternal breast milk samples [CD children (n = 6) and healthy children (n = 18)] were collected 3 months after delivery. Enzyme-linked immunosorbent assays were used to measure TGF-β1, TGF-β2, sIgA, MFG-E8 and sCD14. For microbiota analysis, next generation (Illumina) sequencing, real-time PCR and denaturing gradient gel electrophoresis were used. Phylotype abundance and the Shannon 'H' diversity index were significantly higher in breast milk samples in the CD group. There was higher prevalence of the phyla Bacteroidetes and Fusobacteria, the classes Clostridia and Fusobacteriia, and the genera Leptotrichia, Anaerococcus, Sphingomonas, Actynomyces and Akkermansia in the CD group. The immunological markers were differently associated with some Gram-negative bacterial genera and species (Chryseobacterium, Sphingobium) as well as Gram-positive species (Lactobacillus reuteri, Bifidobacterium animalis). In conclusion, the microbiota in breast milk from mothers of genetically predisposed offspring who presented CD showed a higher bacterial phylotype abundance and diversity, as well as a different bacterial composition, as compared with the mothers of unaffected offspring. These immune markers showed some associations with bacterial composition and may influence the risk for development of CD beyond early childhood.

Indexed as

Celiac DiseaseLimosilactobacillus reuteriMicrobiotaBacteriaChildChild, PreschoolFemaleHumansLipopolysaccharide ReceptorsMilk, HumanLipopolysaccharide Receptors

Identifiers

PMID35459889
PMCPMC9033794
OpenAlexW4224265653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.